Search for Clinical Trial Results
Glomerulosclerosis, Focal Segmental - 25 Studies Found
Status | Study |
Completed |
Study Name: Safety Study of GC1008 in Patients With Focal Segmental Glomerulosclerosis (FSGS) of Single Doses of GC1008 in Patients With Treatment Resistant Idiopathic FSGS Condition: Focal Segmental Glomerulosclerosis Date: 2007-04-20 Interventions:
|
Recruiting |
Study Name: Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children Condition: Focal Segmental Glomerulosclerosis 1 Date: 2014-09-06 Interventions: Device: Liposorber® LA-15 System Liposorber® LA-15 System is an extracorporeal blood purificat |
Completed |
Study Name: A Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS) Condition: Primary Focal Segmental Glomerulosclerosis Date: 2012-08-13 Interventions:
|
Recruiting |
Study Name: Allogenic AD-MSC Transplantation in Idiopathic Nephrotic Syndrome (Focal Segmental Glomerulosclerosis) Condition: Focal Segmental Glomerulosclerosis Date: 2015-03-03 Interventions: Biological: Intravenous injection Intravenous injection of AD-MSC to the patients with FSGS |
Withdrawn |
Study Name: Tacrolimus Treatment of Patients With Idiopathic Focal Segmental Glomerulosclerosis Condition: Focal Glomerulosclerosis Date: 2006-03-13 Interventions: Drug: Tacrolimus Tacrolimus Other Name: Tacrolimus, |
Completed |
Study Name: Prednisone Plus Tripterygium Wilfordii Treatment of Adult Patients With Idiopathic Focal Segmental Glomerulosclerosis Condition:
Date: 2008-12-02 Interventions: Drug: tripterygium wilfordii (TW) Pre 30mg/d +TW 120 mg/d, po for 12 weeks |
Completed |
Study Name: Retinoids for Minimal Change Disease and Focal Segmental Glomerulosclerosis Condition:
|
Active, not recruiting |
Study Name: Predictors of Disease Progression in Primary Focal Segmental Glomerulosclerosis Condition:
|
Completed |
Study Name: Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS) Condition: Focal Glomerulosclerosis Date: 2005-09-10 Interventions:
|
Completed |
Study Name: Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial Condition: Focal Segmental Glomerulosclerosis Date: 2008-12-22 Interventions:
|